97 related articles for article (PubMed ID: 6340820)
1. Levamisole in primary breast cancer. A controlled study in conjunction with l-phenylalanine mustard.
Kay RG; Mason BH; Stephens EJ; Arthur JF; Hitchcock GC; Trindall PL; Rodgers R; Mullins P
Cancer; 1983 Jun; 51(11):1992-7. PubMed ID: 6340820
[TBL] [Abstract][Full Text] [Related]
2. 1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers.
Fisher B; Sherman B; Rockette H; Redmond C; Margolese R; Fisher ER
Cancer; 1979 Sep; 44(3):847-57. PubMed ID: 383274
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
Glucksberg H; Rivkin SE; Rasmussen S; Tranum B; Gad-el-Mawla N; Costanzi J; Hoogstraten B; Athens J; Maloney T; McCracken J; Vaughn C
Cancer; 1982 Aug; 50(3):423-34. PubMed ID: 7046900
[TBL] [Abstract][Full Text] [Related]
5. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.
Fisher B; Fisher ER; Redmond C
J Clin Oncol; 1986 Jun; 4(6):929-41. PubMed ID: 3519883
[TBL] [Abstract][Full Text] [Related]
6. L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.
Fisher B; Carbone P; Economou SG; Frelick R; Glass A; Lerner H; Redmond C; Zelen M; Band P; Katrych DL; Wolmark N; Fisher ER
N Engl J Med; 1975 Jan; 292(3):117-22. PubMed ID: 1105174
[TBL] [Abstract][Full Text] [Related]
7. NSABP trials of adjuvant chemotherapy for breast cancer. A further look at the evidence.
Mueller CB; Lesperance ML
Ann Surg; 1991 Sep; 214(3):206-11; discussion 211-2. PubMed ID: 1670113
[TBL] [Abstract][Full Text] [Related]
8. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
Bonadonna G; Rossi A; Valagussa P; Banfi A; Veronesi U
Cancer; 1977 Jun; 39(6 Suppl):2904-15. PubMed ID: 326384
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Rivkin SE; Green S; Metch B; Glucksberg H; Gad-el-Mawla N; Constanzi JJ; Hoogstraten B; Athens J; Maloney T; Osborne CK
J Clin Oncol; 1989 Sep; 7(9):1229-38. PubMed ID: 2671283
[TBL] [Abstract][Full Text] [Related]
10. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
Fisher B; Glass A; Redmond C; Fisher ER; Barton B; Such E; Carbone P; Economou S; Foster R; Frelick R; Lerner H; Levitt M; Margolese R; MacFarlane J; Plotkin D; Shibata H; Volk H
Cancer; 1977 Jun; 39(6 Suppl):2883-903. PubMed ID: 194679
[No Abstract] [Full Text] [Related]
11. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
Fisher B; Slack N; Katrych D; Wolmark N
Surg Gynecol Obstet; 1975 Apr; 140(4):528-34. PubMed ID: 805475
[TBL] [Abstract][Full Text] [Related]
12. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.
Ejlertsen B; Mouridsen HT; Jensen MB; Andersen J; Andersson M; Kamby C; Knoop AS;
Cancer; 2010 May; 116(9):2081-9. PubMed ID: 20186830
[TBL] [Abstract][Full Text] [Related]
14. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
Klefström P
Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
Fisher B; Redmond C; Brown A; Fisher ER; Wolmark N; Bowman D; Plotkin D; Wolter J; Bornstein R; Legault-Poisson S
J Clin Oncol; 1986 Apr; 4(4):459-71. PubMed ID: 2856857
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary breast cancer with chemotherapy and tamoxifen.
Fisher B; Redmond C; Brown A; Wolmark N; Wittliff J; Fisher ER; Plotkin D; Bowman D; Sachs S; Wolter J; Frelick R; Desser R; LiCalzi N; Geggie P; Campbell T; Elias EG; Prager D; Koontz P; Volk H; Dimitrov N; Gardner B; Lerner H; Shibata H
N Engl J Med; 1981 Jul; 305(1):1-6. PubMed ID: 7015139
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy with levamisole in resectable lung cancer.
Amery WK; Cosemans J; Gooszen HC; Lopes Cardozo E; Louwagie A; Stam J; Swierenga J; Vanderschueren RG; Veldhuizen RW
Recent Results Cancer Res; 1978; 68():268-77. PubMed ID: 379936
[TBL] [Abstract][Full Text] [Related]
18. [Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
Taguchi T; Izuo M; Ogawa N; Hayasaka H; Akai S; Tazima S; Fujii G; Tominaga T; Okamoto T; Kubo K; Yoshida M; Ota K; Sakai K; Hattori T; Inoue G; Nomura Y
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1595-608. PubMed ID: 6764119
[TBL] [Abstract][Full Text] [Related]
19. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer.
Rubens RD; Hayward JL; Knight RK; Bulbrook RD; Fentiman IS; Chaudary M; Howell A; Bush H; Crowther D; Sellwood RA; George WD; Howat JM
Lancet; 1983 Apr; 1(8329):839-43. PubMed ID: 6132179
[TBL] [Abstract][Full Text] [Related]
20. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
Fisher B; Redmond C; Legault-Poisson S; Dimitrov NV; Brown AM; Wickerham DL; Wolmark N; Margolese RG; Bowman D; Glass AG
J Clin Oncol; 1990 Jun; 8(6):1005-18. PubMed ID: 2189950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
